Natera's 'Signatera' detects recurrence of cancer through a blood test

Name: Natera's 'Signatera' detects recurrence of cancer through a blood test
Uploaded: 2025-07-09T01:24:47Z
Duration: 8 min 47 s
Description: Natera CEO Steve Chapman discusses the evolution of the company over ten years and how the company helps cancer patients on 'The Claman Countdown.'

FBN · Jul 9, 2025 · 8m 47sSign Up Now

Already a subscriber?

Natera CEO Steve Chapman discusses the evolution of the company over ten years and how the company helps cancer patients on 'The Claman Countdown.'

Watch Natera's 'Signatera' detects recurrence of cancer through a blood test - FBN | FOX One